Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

PRNB

Principia Biopharma (PRNB)

Principia Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PRNB
DateTimeSourceHeadlineSymbolCompany
2:07PMiHub NewswireFeaturedNanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
02/16/20213:14PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRNBPrincipia Biopharma Inc
11/24/20208:00AMGlobeNewswire Inc.Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus TrialĀ for RilzabrutinibNASDAQ:PRNBPrincipia Biopharma Inc
10/08/20207:01AMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:PRNBPrincipia Biopharma Inc
10/01/20206:06AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRNBPrincipia Biopharma Inc
09/28/20205:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRNBPrincipia Biopharma Inc
09/28/20205:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRNBPrincipia Biopharma Inc
09/28/20205:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRNBPrincipia Biopharma Inc
09/28/20205:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRNBPrincipia Biopharma Inc
09/28/20209:20AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PRNBPrincipia Biopharma Inc
09/28/20209:18AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PRNBPrincipia Biopharma Inc
09/28/20209:16AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PRNBPrincipia Biopharma Inc
09/28/20209:12AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PRNBPrincipia Biopharma Inc
09/28/20208:49AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:PRNBPrincipia Biopharma Inc
09/28/20208:43AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRNBPrincipia Biopharma Inc
09/28/20206:35AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:PRNBPrincipia Biopharma Inc
09/28/20206:31AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PRNBPrincipia Biopharma Inc
09/22/20206:44AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:PRNBPrincipia Biopharma Inc
09/22/20206:32AMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PRNBPrincipia Biopharma Inc
09/17/20208:01AMGlobeNewswire Inc.Principia Announces First Patient Dosed in Phase 2A Trial of Rilzabrutinib in IgG4-Related DiseaseNASDAQ:PRNBPrincipia Biopharma Inc
09/14/20204:34PMEdgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PRNBPrincipia Biopharma Inc
09/10/202010:04AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRNBPrincipia Biopharma Inc
09/10/20208:00AMGlobeNewswire Inc.Neoleukin Therapeutics Announces Appointment of Martin Babler to Board of DirectorsNASDAQ:PRNBPrincipia Biopharma Inc
08/28/20201:44AMDow Jones NewsSanofi to Launch Tender Offer for Principia AcquisitionNASDAQ:PRNBPrincipia Biopharma Inc
08/25/202012:33PMEdgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PRNBPrincipia Biopharma Inc
08/21/20206:01AMEdgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:PRNBPrincipia Biopharma Inc
08/20/20204:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRNBPrincipia Biopharma Inc
08/20/20204:20PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PRNBPrincipia Biopharma Inc
08/19/20201:50PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PRNBPrincipia Biopharma Inc
08/18/20206:01AMEdgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:PRNBPrincipia Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:PRNB